Zoetis Inc. News
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. The company also offers parasiticides; vaccines; anti-infectives; other pharmaceutical products; dermatology; and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products and laboratory; and other non-pharmaceutical products. It markets its products to veterinarians, livestock producers, and pet owners. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.
see moreZoetis Inc. Market News
4d
Zoetis Diagnostics Expansion Gains Momentum After Q2 Results and VitalRADS Integration
- Zoetis strengthens its diagnostic services portfolio as it finalizes the VitalRADS acquisition following Q2 results that underscored diagnostics growth within its Global Diagnostics segment.
18d
Zoetis Advances Diagnostics with VitalRADS Integration and Q2 Momentum
Zoetis completes VitalRADS acquisition and strengthens diagnostics amid solid Q2 performance and expanded Vetscan capabilities.
25d
Zoetis Completes Acquisition of VitalRADS, Boosting Diagnostic Services Amid Flattening Revenue
Zoetis finalized its acquisition of veterinary teleradiology provider VitalRADS in July, expanding its Virtual Reference Lab amid flat Q2 revenue and revised full‑year guidance.
18 Aug at 10:57
Zoetis Stock Declines Amidst Market Volatility and Industry Challenges
Zoetis shares dip amid market volatility and industry challenges.
26 Jul at 17:18
Zoetis Stock Declines Amidst Competitive Pressures and Market Challenges
Zoetis faces stock decline due to competitive pressures and market challenges.